Mr. King is a respected senior healthcare leader who operates with a strong emphasis on deeply understanding the healthcare industry, strategic planning, “playing the long game,” and staying ahead of rapidly evolving industry trends and challenges. He uses the insights gained in his 20+ year career as a healthcare leader in providing strategic and operational advice to a number of industry stakeholders.

Mr. King most recently served as executive chair and CEO of Laboratory Corporation of America Holdings (Labcorp – NYSE: LH). Under his leadership, Labcorp transformed from a pure-play U.S. testing laboratory into a leading global life sciences company — tripling in size through a combination of organic growth and strategic acquisitions, entering the Fortune 500, and being named to Fortune’s List of World’s Most Admired Companies. It is now the world’s largest clinical laboratory and second-largest drug development business. In 2019, Forbes named Mr. King to its list of America’s Most Innovative Leaders. Prior to joining Labcorp, Mr. King was partner at Hogan & Hartson LLP (now Hogan Lovells) where he was a key leader in the firm’s healthcare fraud and abuse practice, representing national healthcare companies in investigations and litigation. Mr. King was also an Assistant U.S. Attorney for the District of Maryland.

Mr. King is the Executive Chairman of ScribeAmerica, a leading provider of healthcare workforce solutions; is the non-executive chairman of Privia Health (NASDAQ: PRVA); and also serves on the boards of ZimVie (NASDAQ: ZIMV), binx health, and VaxCare. Mr. King’s extensive commitment to community service also includes serving as board chair of PATH, a nonprofit global health organization; board member of Novant Health, a multi-state integrated health system; member of the advisory board and executive committee of Duke University’s Robert J. Margolis, MD, Center for Health Policy; and board member of The Emily K Center, a college-readiness center founded by Duke coach Mike Krzyzewski. Mr. King previously served on the board of Cardinal Health (NYSE: CAH), a Fortune 20 healthcare company, and the American Clinical Laboratory Association, where he served as board chair from 2010 to 2014.

Mr. King holds a bachelor’s degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from the University of Pennsylvania Law School.

Dr. Tony Andrulonis leads operations throughout the ScribeAmerica family of solutions, including ScribeAustralia. In this role he collaborates cross-functionally with executive, senior and local management to define key performance objectives, and develop strategies to address healthcare delivery challenges.

As an emergency medicine physician, Dr. Andrulonis has driven groundbreaking results in clinical care, and administrative efficiency over the course of his career. With expertise improving the quality of life for patients and providers, he guides health systems through the transition to value-based care.

Prior to joining ScribeAmerica, Dr. Andrulonis served as the President of Emergency Medicine at Envision Health, and Chief of the Department of Emergency Medicine at Baptist Health in Miami, Florida. As a Federal Emergency Management Agency (FEMA) Task Force member, Dr. Andrulonis contributed to the emergency response for 9/11 and Hurricane Katrina. He is a sought out speaker, and was recognized by the American College of Emergency Physicians (ACEP) as a “Hero of Emergency Medicine” during their 40th Anniversary celebration.

Dr. Andrulonis graduated from the University of Pittsburgh School of Medicine and completed a residency at the University of Pennsylvania. He holds an MBA from Northwestern, Kellogg School of Management and served as an Assistant Professor of Emergency Medicine at the University of Pennsylvania.

Amanda works closely with hospital partners and staffing groups across the country to deliver customized healthcare solutions at the point of care. She has worked in the medical scribe industry since 2002, beginning her career as a scribe leader and implementer. Her work has helped shape today’s modern medical scribe industry.

Amanda has served in business development roles strategizing with partners as well as overseeing operations teams focused on standardization and execution. She has led national teams through periods of dynamic change, including expansions and acquisitions. Amanda’s experience and expertise in the healthcare industry paired with her legal training allows her to work with our partners to deliver innovative and compliant solutions across the care continuum.

Amanda graduated from Texas Christian University with a degree in Biology and earned a JD from Texas A & M Law School, where she graduated Magna Cum Laude. She resides in the Dallas/Fort Worth area with her husband, two sons, and two stepdaughters.